Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial
Stopped early · Not applicable
Conditions studied: Surgical Wound Infection, Cesarean Section
In brief
The Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean Trial is a large pragmatic multi-center randomized clinical trial designed to evaluate the effectiveness, safety and cost-effectiveness of prophylactic negative pressure wound therapy (NPWT) - a closed, sealed system that applies negative pressure to the wound surface via a single-use, battery-powered, portable device - to decrease surgical site infections (SSIs) in obese women.
Key facts
- Study ID
- NCT03009110
- Run by
- Indiana University
- People needed
- 1624
- Starts
- 2017-02-08
- Expected to finish
- 2019-11-13
- Last updated by the study team
- 2023-06-01
Who can join
Age: 16 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Gestational age ≥23weeks
- BMI≥30 Pre-pregnancy or BMI at first prenatal visit
- Planned or unplanned cesarean delivery
You may not qualify if…
- Non-availability for postoperative follow-up
- Contraindication to NPWT applicable to women undergoing cesarean: Pre-existing infection around incision site, Bleeding disorder, Therapeutic anticoagulation, Irradiated skin, Allergy to any component of the dressing (e.g. silver, acrylic, silicone, adhesive tape)
Where it is running
- University of Alabama Medical Center — Birmingham, Alabama, United States
- Eskenazi Hopsital — Indianapolis, Indiana, United States
- Methodist Hospital — Indianapolis, Indiana, United States
- Ochsner Baptist Medical Center — New Orleans, Louisiana, United States
- Barnes-Jewish Hospital — St Louis, Missouri, United States
- Mercy Hosptial St Louis — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.